Abstract:Some members of the transient receptor potential vanilloid (TRPV) subfamily of cation channels are thermosensitive. Earlier studies have revealed the distribution and functions of these thermo-TRPVs (TRPV1–4) in various organs, but their expression and function in the human esophagus are not fully understood. Here, we probed for the expression of the thermo TRPVs in one nontumor human esophageal squamous cell line and esophageal squamous cell carcinoma (ESCC) cell lines. TRPV1 and TRPV4 proteins were found to be upregulated in ESCC cells. As we all know, cisplatin is a commonly used chemotherapy drug. Whether cisplatin can affect the expression of ion channels in esophageal cancer cells, and whether the different expression of ion channels can also affect the sensitivity of cisplatin. In order to provide more possibility for clinical drug treatment of esophageal cancer, we used small molecular substances related to TRP channel to observe the effect of chemotherapy drugs on esophageal cancer. The expression of TRPV1 in esophageal carcinoma was detected by immunohistochemistry. In order to analyze the sensitivity of esophageal cancer cells to cisplatin in vitro, the sensitivity of esophageal cancer cells to cisplatin in five different concentrations (10 μ mol, 50 μ mol, 100 μ mol, 250 μ mol, 500 μ mol,) was measured by MTT method. Western blot was used to detect the effect of cisplatin on the expression of TRPV1 in esophageal cancer cells. Immunohistochemical analysis showed that the expression of TRPV1 in esophageal cancer was significantly higher than that in normal esophageal tissue. MTT assay showed that cisplatin could significantly inhibit the growth of esophageal cancer cell line Eca109. The OD value of Eca109 cell line treated with different concentrations of cisplatin decreased in different degrees, the difference was statistically significant (P < 0.05). The inhibition rate increased with the increase of cisplatin concentration (1.3%, 6.5%, 6.8%, 15.2%, 32.4%). When the drug concentration reached 500 μ mol, the inhibition of cell proliferation reached the peak. Western blot showed that the expression of TRPV1 ion channel was the weakest in the blank control group after culturing esophageal cancer cell line Eca109 for 24 hours with different concentrations of cisplatin, and the expression of TRPV1 ion channel increased with the increase of cisplatin concentration from 10 μ mol to 500 μ mol. In summary, in this study we found that thermo- TRPVs were functionally expressed in nontumor esophageal squamous cells and were upregulated in esophageal squamous cell carcinoma cells When the concentration of cisplatin increased, it had obvious inhibitory effect on esophageal cancer cells. At the same time, it can promote the expression of TRPV1 ion channel, which shows that the expression of TRPV1 and TRPV4 ion channel can promote cisplatin to play an important role in the development of ESCC chemotherapy and inhibit the proliferation of tumor cells.

Study On The Role Of Transient Receptor Potential C6 Channels In Esophageal Squamous Cell Carcinoma Radiosensitivity

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.

TMT‐Based Quantitative Proteomic Profiling of Human Esophageal Cancer Cells Reveals the Potential Mechanism and Potential Therapeutic Targets Associated With Radioresistance

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma

EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway

The ATPase Subunit of ATP6V1C1 Inhibits Autophagy and Enhances Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

High Expression of Transient Potential Receptor C6 Correlated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Trpv 1 Regulates The Proliferation And Cisplatin Sensitivity Of Esophageal Cancer

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

[High Throughput-Targeted Sequencing Panel for Exploring Radiosensitivity Associated Genes in Esophageal Squamous Cell Carcinoma].

Effects and Underlying Mechanisms of Homologous Recombina-Tion-associated Protein XRCC3 on Esophageal Squamous-Cell Carci-Noma Radiotherapy Response

Targeting CAFs-Secreted TGFβ1 Signaling to Radiosensitize Esophageal Squamous Cell Carcinoma in Vitro and in Vivo

Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma

Role of Vascular Endothelial Growth Factor in Radiotherapy Resistance to Esophageal Squamous Cell Carcinoma

PD-1 Inhibitor Enhanced Radiosensitivity by Reactivating T Cells and Inducing G2/M Phase Arrest in Esophageal Squamous Cell Carcinoma

Identification of Radioresponsive Genes in Esophageal Cancer from Longitudinal and Single Cell Exome Sequencing

PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1

Effection of Cell Cycle and Radiosensitivity of CPT-11 on Esophageal Cancer Cell Line-109

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy